Key result
Among 36 Chinese patients with dysferlinopathy, 43 DYSF mutations were identified (31 novel) across five clinical phenotypes, highlighting significant clinical and genetic heterogeneity.
Cohort (n=36)
Highlights the clinical heterogeneity and high proportion of novel DYSF mutations in Chinese patients with dysferlinopathy.
Answers are grounded in this paper and cite their sources.
Largest Chinese dysferlinopathy cohort details phenotypes and mutations; extends spectrum knowledge but leaves generalizability open.
BACKGROUND AND AIMS: Dysferlinopathies are a group of autosomal recessive muscular dystrophies caused by mutations in the dysferlin gene. This study presents clinical features and the mutational spectrum in the largest cohort of Chinese patients analyzed to date. PATIENTS AND METHODS: A total of 36 unrelated Chinese patients with diagnostic suspicion of dysferlinopathy were clinically and genetically characterized. RESULTS: Patients were divided into five phenotypes: 19 patients with limb girdle muscular dystrophy (LGMD) type 2B, 10 with Miyoshi myopathy (MM), 1 with distal anterior compartment myopathy (DACM), 3 with exercise intolerance, and 3 with asymptomatic hypercreatine phosphokinasemia (hyperCPKemia). Thirty-one patients showed an absence or drastic reduction of dysferlin expression by Westernblot. Forty-three mutations were identified in DYSF, including 31 novel. CONCLUSION: Our study underlines clinical heterogeneity and a high proportion of novel mutations in Chinese patients affected with dysferlinopathy.
No takes yet. Share an insight, caveat, or question.
Xi et al. (2014) conducted a cohort in Dysferlinopathy (n=36). DYSF gene mutations was evaluated on Clinical phenotypes and DYSF mutations. Among 36 Chinese patients with dysferlinopathy, 43 DYSF mutations were identified (31 novel) across five clinical phenotypes, highlighting significant clinical and genetic heterogeneity.
Synapse has enriched 10 related papers. Consider them for comparative context: